Jürgen Steffgen

Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

Stefan Schreiber, Brian G. Feagan, Geert D’Haens et al. · Clinical Gastroenterology and Hepatology · 2006 · 191 citations

Medicine, Immunology, Pharmacology +15

Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts

Dominik Kobold, Anka Grundmann, Fabio Piscaglia et al. · Journal of Hepatology · 2002 · 95 citations

Medicine, Cell Biology, Molecular Biology +17

Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment

Andreas Erhardt, Katja Deterding, Yves Benhamou et al. · Antiviral Therapy · 2009 · 71 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study

Sudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński et al. · Annals of the Rheumatic Diseases · 2019 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells

Abdul R. Asif, Jürgen Steffgen, Maria Metten et al. · Pflügers Archiv - European Journal of Physiology · 2004 · 49 citations

Life Sciences, Cell Biology, Endocrinology +10